Serum Institute of India Pvt. Ltd. manufactures several vaccines, which include Polio, Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines. 65% children in the world are estimated to receive at least one vaccine manufactured by Serum Institute. Vaccines manufactured by the Serum Institute are accredited by the World Health Organization.
Serum Institute of India – Protection from birth onwards
Serum Institute Life Sciences Private Limited (SILS) and Biocon Biologics Limited (BBL) announced a strategic alliance to develop antibodies for infectious diseases such as dengue, HIV, and others.
In June 2021, SII announced plans to launch Novavax's COVID-19 vaccine 'Covovax' in India by September 2021Government of India signed a deal to procure 20 million doses of its COVID-19 vaccination.
Launched India’s first fully indigenously developed pneumococcal vaccine, 'Pneumosil'
|2016||Launched world’s first rabies human monoclonal antibody, recombinant|
|2014||Launched oral polio vaccine|
|2012|| Acquired Bilthoven Biologicals, Netherlands |
Launched Trivalent seasonal influenza vaccine
|2011||Launched injectable inactivated polio vaccine|
|2010||Launched H1N1 influenza vaccine|
|2009||Launched liquid pentavalent vaccine (DPT-HepB-Hib) (PENAVAC SD/PFS)|
|2007||Launched Hib vaccine and BCG vaccine for bladder cancer|
|2002||Launched BCG vaccine|
|2001||Launched Hepatitis B vaccine|
|1993||Launched MMR vaccine|
|1989||Launched measles vaccine|
|1974||Commenced production of DTP vaccine|